DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20185411

Comparison between intramuscular oxytocin versus oxytocin with sublingual misoprostol in blood loss reduction among risk of postpartum hemorrhage vaginal deliveries

M. Vanitha, S. Sujathasenthil, Heber Anandan

Abstract


Background: This study compares the efficacy of intramuscular oxytocin and oxytocin with sublingual misoprostol administration among the primary postpartum hemorrhage (PPH) mothers of vaginal deliveries. The aim is to compare the effectiveness of intramuscular oxytocin versus oxytocin with sublingual misoprostol in blood loss reduction among women at risk of PPH undergoing vaginal deliveries.

Methods: Each group, 50 mothers were selected from the risk of PPH vaginal mothers in the labour ward of the study area.

Results: The two groups’ mothers were not statistically significantly differed (P>0.05) in respect of their demographic and clinical variables such as age, gravida, risk factors, the onset of labour and type of delivery. The mean blood loss of group I was 315.4±111.4 ml and group II mean blood loss was 241.4±191.2 ml. The difference between the two groups’ blood losses was statistically significant (P<0.05).

Conclusions: Oxytocin with sublingual misoprostol significantly reduced the blood loss during 3rd stage labour than only oxytocin administration.


Keywords


Blood loss, Oxytocin, Oxytocin with misoprostol, Vaginal delivery-PPH risk

Full Text:

PDF

References


WHO. Postpartum care of mother and newborn, A practical guide, Safe mothehood unit, WHO Geneva, 1998.

WHO for prevention of postpartum heamorrhage, WHO Geneva, 2007 guidelines.

World Health Organization (2012). WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization.

Dildy Iii GA. Postpartum hemorrhage: new management options. Clinic Obstet Gynecol. 2002;45(2):330-44.

Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Systematic Reviews. 2013(10).

Nordstrom L, Fogelstam K, Fridman G, Larsson A, Rydhstroem H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol. 1997;104:781-6.

Bugalho A, Daniel A, Faundes A, Cunha M. Misoprostol for prevention of postpartum hemorrhage. Int J Gynaecol Obstet. 2001;73:1-6.

Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99(Suppl2):S160-7.

Katzung GB. Basic principles of pharmacology. In: Katzung GB, MastersSB, Trevor AJ, eds. Basic and clinical pharmacology. 12th ed. New York: McGraw-Hill Medical; 2010.

International Federation of Gynecology and Obstetrics. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet. 2012;119:213-4.

Bellad MB, Tara D, Ganachari MS, Mallapur MD, Goudar SS, Kodkany BS, et al. Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial. Br J Obstet Gynaecol. 2012;119(8):975-82.

Shrestha A, Dongol A, Chawla CD, Adhikari RK. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage. Kathmandu Univ Med J. 2011;9(1):8-12.

Vimala N, Mittal S, Kumar S. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section. Int J Gynaecol Obstet. 2006;92:106-10.

Chandhiok N, Dhillon BS, Datey S, Mathur A, Saxena NC. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynaecol Obstet. 2006;92:170-5.

Cook CM, Spurrett B, Murray H. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labor. Aus N Z J Obstet Gynaecol. 1999;39:414-9.

Ng PS, Chan AS, Sin WK, Tang LC, Cheung KB, et al. A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labor. Hum Reprod. 2001;16:31-5.

Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet. 2006;368:1248-53.

Singh G, Radhakrishnan G, Guleria K. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor. Int J Gynaecol Obstet. 2009;107:130-4.

Haque N, Bilkis L, Haque N, Bari MS, Haque S. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage. Mymensingh Med J. 2009;18(supplement 1):S40-4.

Gülmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre double-blind randomized controlled trial to evaluate the use of misoprostol in the management of the third stage of labour. 2001;358:689-95.